NSPR
InspireMD·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 1
Ample Liquidity
Significant Net Income Decline
Revenue Beats Expectation
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About NSPR
Inspiremd, Inc.
A developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke
Healthcare Equipment and Supplies
02/29/2008
05/24/2021
NASDAQ Stock Exchange
85
12-31
Common stock
4 Menorat Hamaor St., Tel Aviv, Israel 6744832
--
InspireMD, Inc., was incorporated in Delaware on February 29, 2008. The company, originally known as Saguaro Resources Corporation, is involved in the acquisition, exploration and development of natural resources. On March 28, 2011, the company changed its name from "Cactus Resources Co., Ltd." to "InspireMD, Inc.". The Company is a medical device company focused on developing and commercializing proprietary MicroNe stent platform technology for the treatment of complex vascular and coronary artery diseases. A stent is an expandable "stent-like" device, usually made of metal material, inserted into an artery to widen internal channels and improve blood flow. MicroNet is a micron mesh sleeve that is wrapped around a stent and provides embolic protection during stent implantation.
Earnings Call
Q1/2025
Estimate EPS-0.2
Actual EPS-0.22
Estimate Revenue1.45M
Actual Revenue1.53M
InspireMD's Q1 2025: Navigating FDA Approval Contradictions and Strategic Hiring Challenges
May 20,2025 01:24
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS-0.26
Actual EPS-0.26
Estimate Revenue1.52M
Actual Revenue1.78M
InspireMD's Q2 2025: Key Contradictions in FDA Approval, Product Launches, and U.S. Market Strategy
Aug 05,2025 12:38
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
NSPR has released its 2025 Q3 earnings. EPS was reported at -0.17, versus the expected -0.19, beating expectations. The chart below visualizes how NSPR has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
NSPR has released its 2025 Q3 earnings report, with revenue of 2.52M, reflecting a YoY change of 39.39%, and net profit of -12.71M, showing a YoY change of -61.06%. The Sankey diagram below clearly presents NSPR's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
